CompletedNot Applicable

AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA

United States66 participantsStarted 2010-07

Plain-language summary

The purpose of this study is to compare two types of supraglottic airways (SGA), the Ambu® Aura-I and the Intubating Laryngeal Mask Airway (ILMA), regarding time to intubate, ease of insertion, sealing properties, optical view upon fiberoptic examination regarding the Ambu Aura-I, ease and success rate of intubation, airway morbidity, and patient comfort in patients undergoing general anesthesia for elective surgery.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult surgical Candidates Aged 18-80 years * ASA I-III * Mallampati Score of I or II * BMI ≤ 35 kg/m2 * Presenting for elective surgery * Require General Endotracheal Anesthesia. Exclusion Criteria: * Previously known difficult airway, * Emergency status * Require prone positioning * Interincisor distance \< 2.5cm * Thyromental distance \< 5cm * Clinically suspected difficult airway * Contraindications to LMA Insertion, such as Reflux disease * Patients who do not require endotracheal intubation * Indications for Rapid Sequence Induction (RSI)

What they're measuring

Total Intubation Time

Timeframe: Duration of Intubation, including supraglottic airway (SGA) insertion and endotracheal tube (ETT) insertion

Trial details

NCT IDNCT01656967

SponsorThe University of Texas Health Science Center, Houston

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-01

Results submitted2016-03-22

View on ClinicalTrials.gov More Supraglottic Airway trials